Literature DB >> 23434160

Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome.

Diana Ferraro1, Anna Maria Simone, Roberta Bedin, Veronica Galli, Francesca Vitetta, Lucia Federzoni, Roberto D'Amico, Elisa Merelli, Paolo Frigio Nichelli, Patrizia Sola.   

Abstract

We reviewed the records of 391 patients who had presented with a Clinically Isolated Syndrome and selected 205 who had performed a baseline spinal tap and MRI scan. We studied cerebrospinal fluid (CSF) and serum IgM oligoclonal bands (IgMOB) using agarose gel isoelectric focusing and analyzed the impact of baseline clinical, MRI and CSF variables on the risk of conversion to clinically definite multiple sclerosis, i.e. on the risk of a clinical relapse. At survival analysis, a lower age at onset, an onset with optic neuritis and the presence of CSF-restricted IgMOB increased the risk of a relapse. Only the presence of CSF-restricted IgMOB predicted a relapse within one year.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23434160     DOI: 10.1016/j.jneuroim.2013.01.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

Review 1.  Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Authors:  Charlotte E Teunissen; Arjan Malekzadeh; Cyra Leurs; Claire Bridel; Joep Killestein
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

2.  Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients.

Authors:  Bonaventura Casanova; Laura Lacruz; María Luisa Villar; José Andrés Domínguez; María Carcelén Gadea; Francisco Gascón; Javier Mallada; David Hervás; María Simó-Castelló; José Carlos Álvarez-Cermeño; Carmen Calles; Javier Olascoaga; Lluís Ramió-Torrentà; Carmen Alcalá; Angeles Cervelló; Isabel Boscá; Francisco Carlos Pérez-Mirallles; Francisco Coret
Journal:  Neurol Sci       Date:  2018-06-07       Impact factor: 3.307

3.  Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Authors:  Jessica Frau; Luisa Maria Villar; Claudia Sardu; Maria Antonietta Secci; Lucia Schirru; Diana Ferraro; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Roberta Bedin; Patrizia Sola; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  J Neurol       Date:  2017-12-22       Impact factor: 4.849

4.  Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome.

Authors:  Diana Ferraro; Veronica Galli; Anna Maria Simone; Roberta Bedin; Francesca Vitetta; Elisa Merelli; Paolo Frigio Nichelli; Patrizia Sola
Journal:  J Neurovirol       Date:  2016-11-22       Impact factor: 2.643

5.  Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.

Authors:  Christiane Gasperi; Anke Salmen; Gisela Antony; Antonios Bayas; Christoph Heesen; Tania Kümpfel; Ralf A Linker; Friedemann Paul; Martin Stangel; Björn Tackenberg; Florian Then Bergh; Clemens Warnke; Frank Weber; Heinz Wiendl; Brigitte Wildemann; Uwe K Zettl; Ulf Ziemann; Frauke Zipp; Hayrettin Tumani; Ralf Gold; Bernhard Hemmer
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

6.  Experimental laboratory biomarkers in multiple sclerosis.

Authors:  Borros Arneth; Jörg Kraus
Journal:  Wien Med Wochenschr       Date:  2022-03-07

Review 7.  Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices.

Authors:  Carlo Tornatore; J Theodore Phillips; Omar Khan; Aaron E Miller; Mark Hughes
Journal:  Neurol Clin Pract       Date:  2016-08

8.  Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study.

Authors:  Carmen Alcalá; F Gascón; F Pérez-Miralles; S Gil-Perotín; A Navarré; I Boscá; F Coret; B Casanova
Journal:  J Neurol       Date:  2018-05-21       Impact factor: 6.682

9.  Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.

Authors:  Paulo Diniz da Gama; Luís dos Ramos Machado; José Antonio Livramento; Hélio Rodrigues Gomes; Tarso Adoni; Rogério de Rizo Morales; Rodrigo Assad Diniz da Gama; Daniel Assad Diniz da Gama; Marco Aurélio Lana-Peixoto; Yara Dadalti Fragoso; Dagoberto Callegaro
Journal:  Biomed Res Int       Date:  2015-07-29       Impact factor: 3.411

10.  Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome.

Authors:  Enric Monreal; Susana Sainz de la Maza; Lucienne Costa-Frossard; Paulette Walo-Delgado; Javier Zamora; José Ignacio Fernández-Velasco; Noelia Villarrubia; Mercedes Espiño; Daniel Lourido; Paloma Lapuente; Inmaculada Toboso; José Carlos Álvarez-Cermeño; Jaime Masjuan; Luisa María Villar
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.